ARCH Ventures logo
  • About
  • Portfolio
  • Team
  • News
  • Contact

News

June 29, 2022 Press Releases from ARCH Venture Partners   |   Share

ARCH Venture Partners Announces $2.975 Billion Fund XII to Create and Fund Early Stage Biotechnology Companies

June 7, 2022 Press Releases from ARCH Venture Partners   |   Share

ARCH Venture Partners Announces Promotions and New Appointment

May 19, 2022 Portfolio News from ARCH Venture Partners   |   Share

Bob Nelsen-founded Resilience inks manufacturing pact with ARCH-backed Be Bio

May 16, 2022 Media Coverage from ARCH Venture Partners   |   Share

John Maraganore named on Fierce’s Most Influential People in BioPharma list

May 9, 2022 Media Coverage from ARCH Venture Partners   |   Share

John Maraganore’s “Reflections on Alnylam,” published in Nature Biotech

April 26, 2022 Portfolio News from ARCH Venture Partners   |   Share

Irv Weissman’s lab spins out Pheast Therapeutics to target new ‘don’t eat me’ signal, $76M Series A led by ARCH Venture

April 14, 2022 Portfolio News from ARCH Venture Partners   |   Share

ARCH leads $130M infusion into Be Bio’s long pursuit of B cell therapies for rare disease, cancer

March 14, 2022 Portfolio News from ARCH Venture Partners   |   Share

Nutcracker Therapeutics with Bob Nelsen backing lands $167M to develop its own cancer drugs

March 9, 2022 Portfolio News from ARCH Venture Partners   |   Share

Exclusive: ARCH and GV are building a large startup focused on mitochondrial diseases

February 24, 2022 Portfolio News from ARCH Venture Partners   |   Share

With a new startup, ARCH and Takeda wade into growing search for a Swiss Army knife RNA drug

February 22, 2022 Media Coverage from ARCH Venture Partners   |   Share

Bob Nelsen makes the STAT News 2022 STATUS list. Multiple founders and leaders of ARCH portfolio companies also named, including Jennifer Doudna, Yvonne Greenstreet, Leroy Hood, Daphne Koller and David Liu.

January 20, 2022 Portfolio News from ARCH Venture Partners   |   Share

Super-resolution microscope maker ONI nabs $75M for US expansion, Series B led by ARCH Venture

Posts navigation

Older posts
COMPANY
  • About
  • Portfolio
  • Team
  • News
  • Contact
LOCATIONS
  • Chicago, IL
  • Seattle, WA
  • San Francisco, CA
  • Dublin, Ireland
©2022 Arch Venture Partners

Terms of Use
Privacy Policy

CONNECT